IS LAB
MLS 412 Immunology & Serology — High-Yield Exam Reviewer
EVACUATED TUBE SYSTEM (ETS)
Vein Priority: Median Cubital (1st) → Cephalic (2nd) → Basilic (3rd/last resort, near basilic artery)
Key Steps to Remember:
Tourniquet: <1 min to avoid hemoconcentration (darker blood)
Release tourniquet when backflow is established
Bevel facing up on needle insertion
Mix additive tubes: 3–8 gentle inversions
Label tubes before leaving bedside
Discard needle + holder as a unit into sharps container (red)
Order of Draw: Blood cultures → Light Blue (SPS) → Red → SST → PST → Green → Lavender/EDTA → Gray Mnemonic: "Be careful, Stop Light, Red, Stay, Put, Green, LEts, Go"
Special Handling:
Ammonia → crushed ice
Cold agglutinin → body temperature
Bilirubin → protect from light (photosensitive)
Dietary Requirements:
FBS: 8–10 hrs
Lipid Profile: 10–12 hrs
FBS + LP: 10 hrs
SERUM DILUTION
Formula: Dilution = Volume of Solute / Total Volume
Simple Dilution: single step reduction
Dilution factor = denominator (whole number)
Example: 1:20 dilution of 2 mL → Serum = 0.1 mL; Diluent = 1.9 mL
Serial Dilution: stepwise, consistent factor each step
Most common: two-fold (doubling) dilution
Used to determine titer (strength of antibody)
Final dilution = product of all individual dilutions
BASIC SEROLOGICAL PRINCIPLES
Serology: identifies/measures antigens, antibodies using body fluids (mainly serum)
Key Terms:
Affinity: strength of ONE antibody site + ONE epitope
Avidity: OVERALL strength of multiple binding sites (IgM has highest avidity — 10 binding sites)
Cross-reactivity: antibody binds structurally similar antigen (e.g., cowpox/smallpox)
Paratope: antibody determinant (binds antigen)
Epitope: antigen determinant (binds antibody)
Sensitization: Ag+Ab bind, NO visible reaction (Step 1)
Lattice formation: visible agglutination (Step 2)
Titer: highest dilution showing POSITIVE result
Seroconversion: antibodies start to APPEAR
Seroreversion: antibodies start to DISAPPEAR
Factors Influencing Ag-Ab Reactions:
pH: 6.8–7.0 (near physiological)
Temperature: IgM → 4–27°C (colder = igMalamig); IgG → 30–37°C (warmer = igGang)
Concentration: Zone of equivalence = best reaction
Prozone: excess antibody → false negative
Postzone: excess antigen → false negative
Centrifugation: catalyst, speeds up lattice formation
Immunoglobulin Abundance: IgG > IgA > IgM > IgD > IgE (GAMDE)
Primary vs. Secondary Immune Response:
Feature | Primary | Secondary |
|---|---|---|
Lag Phase | Longer | Shorter |
Antibody Isotype | IgM then IgG | Predominantly IgG |
Titer | Lower | Higher |
Duration | Short-lived | Long-lasting |
PRECIPITATION TECHNIQUES
Precipitation: soluble antigen + soluble antibody = insoluble complex
Turbidimetry: measures REDUCTION in light intensity (detector in line with light)
Nephelometry: measures SCATTERED light at 10–90° angle; amount scattered = index of concentration
Rate Nephelometry: measures rate of increase in light scattering after antibody is added
Radial Immunodiffusion (RID):
Single diffusion; antibody in gel, antigen diffuses
Product: precipitation ring
Bigger diameter = higher antigen concentration
Mancini (Endpoint): diameter² ∝ concentration (measure after diffusion complete)
Fahey (Kinetic): diameter ∝ log concentration (measure during diffusion)
Mnemonic: Fahey = Kinetic; Mancini = Endpoint (James RID FAKME)
Ouchterlony Double Immunodiffusion:
Both antigen AND antibody diffuse
Product: precipitation lines
Identity → smooth arc
Nonidentity → lines cross
Partial identity → spur formation
AGGLUTINATION
Agglutination Stages:
Sensitization (rapid, reversible, no visible reaction)
Lattice formation (visible clumping)
Types:
Type | Antigen | Detects | Example |
|---|---|---|---|
Direct | Naturally on cell | Ab or Ag | Blood typing |
Hemagglutination | Natural RBC antigens | Ab | ABO typing |
Passive (Indirect) | Coated on carrier | Antibodies | CRP, RF, ASO |
Reverse Passive | Antibody on carrier | Antigens | RPR |
Coagglutination | Protein A on S. aureus Fc | Antigens | S. aureus Ag |
Viral Hemagglutination | Viral RBC receptors | Antigens | Influenza |
Agglutination Inhibition | Haptens on carrier | Antigen (by inhibition) | Pregnancy test |
Hemagglutination (Blood Typing):
Blood Type | Antigen | Antibody |
|---|---|---|
A | A | Anti-B |
B | B | Anti-A |
AB | AB | None |
O | None | Anti-A & Anti-B |
Forward Typing: packed RBC + known antibody → detect ANTIGEN
Blue = Anti-A; Yellow = Anti-B; Colorless = Anti-D
Reverse Typing: patient plasma + known RBCs → detect ANTIBODY
Coagglutination: Protein A binds Fc region of IgG; antigen binds FAB region
Agglutination Inhibition:
Successful inhibition = POSITIVE
Unsuccessful inhibition = NEGATIVE
Hemagglutination Inhibition: absence of agglutination = antibody present = POSITIVE
COMPLEMENT FIXATION TEST
Stage 1: Antigen + Patient Serum → if antibodies present → complement is FIXED/consumed
Stage 2: Add sensitized sheep RBCs
Positive (Ab present): complement consumed → NO hemolysis (no lysis of RBCs)
Negative (No Ab): free complement available → HEMOLYSIS occurs
Counterintuitive: No hemolysis = POSITIVE
Heat inactivation: 56°C for 30 minutes
LABELED IMMUNOASSAYS
Competitive: labeled vs unlabeled antigen compete for limited Ab sites
More patient antigen → less label bound → LOWER signal
Inverse relationship: signal ↑ = antigen ↓
Noncompetitive (Sandwich): antibody excess; signal directly proportional to antigen concentration
Heterogeneous: requires separation step Homogeneous: no separation step; faster but less sensitive
ELISA Types:
Direct: primary antibody with label
Indirect: secondary labeled antibody
Sandwich/Capture: antigen between two antibodies
Competitive: labeled vs unlabeled antigen
Radioimmunoassay (RIA): uses radioactive label (¹²⁵I most popular)
RIST: measures total serum IgE
RAST: detects allergen-specific IgE
Immunofluorescence:
Direct IFA: fluorescent antibody added to unknown antigen on slide; best for antigen detection
Indirect IFA: patient serum + known antigen → anti-human Ig with fluorescent tag; best for antibody identification
C-REACTIVE PROTEIN (CRP)
Nature: pentraxin family (5 subunits); synthesized by hepatocytes; increases up to 1000-fold in inflammation
Stimulated by: IL-6 (from activated macrophages/monocytes)
Principle: Reverse Passive Agglutination
Unknown: CRP (antigen)
Known: latex particles coated with anti-CRP antibody (polystyrene)
Agglutination = CRP > 6 IU/mL = POSITIVE
CRP Elevated In: viral/bacterial infections, gout, RA, myocardial infarction, acute rheumatic fever
Note: CRP does NOT spike significantly in SLE or RA (autoimmune conditions)
Specimen: red-top or gold-top tube; no fasting required
Reject: lipemia, hemolysis, bacterial contamination
Refrigerate: 2–8°C up to 24 hrs; freeze at –20°C longer
Qualitative (Screening): agglutination = CRP > 6 IU/mL → proceed to semi-quantitative
Semi-Quantitative Conversion: titer × 6 = CRP in mg/L
Example: titer 1:4 → 4 × 6 = 24 mg/L
RHEUMATOID FACTOR (RF)
Disease: Rheumatoid Arthritis (RA) — systemic autoimmune disorder; destroys bone/cartilage
Key Features:
Pannus formation (invasive granulation tissue in joints)
Osteoclast overactivation → bone erosion
TNF-α regulates osteoclast/osteoblast balance
Two Key Antibodies:
RF (IgM): directed against Fc portion of IgG; not specific (also in SLE, Sjögren's, syphilis, hepatitis)
Anti-CCP: better and more specific than RF for RA
Principle: Passive Agglutination
Unknown: Rheumatoid Factor (antibody)
Known: latex particles coated with human IgG (antigen)
Agglutination = RF present
Strongest environmental risk: cigarette smoking (doubles risk)
Specimen: same as CRP (red-top, no fasting)
Reagent color: WHITE (vs CRP = Blue; ASO = Yellow)
Semi-Quantitative: titer × 12 = RF in IU/mL (some kits use factor 20)
Example: 1:4 → 4 × 12 = 48 IU/mL; OR 4 × 20 = 80 IU/mL
ANTISTREPTOLYSIN O (ASO)
Causative Agent: Group A Streptococcus (Streptococcus pyogenes)
Virulence Factors:
Protein F → attachment
Hyaluronic acid capsule → inhibits phagocytosis (mimics host)
M protein → major virulence factor; antiphagocytic (board exam answer)
Streptolysin O → oxygen-labile; subsurface hemolysis; more destructive
Streptolysin S → oxygen-stable; surface hemolysis
Streptokinase → activates plasminogen → plasmin → dissolves clots
DNase → degrades DNA
Hyaluronidase → "spreading factor"; breaks down connective tissue
C5a peptidase → destroys complement chemotactic factors
Streptococcal pyogenic exotoxins → superantigens → cytokine storm
Sequelae (complications, NOT primary infections):
Rheumatic Fever (M protein mimics heart tissue → molecular mimicry)
Acute Post-Streptococcal Glomerulonephritis (APSGN) → antigen-antibody complex trapped in glomeruli → hematuria
ASO Test Purpose: detect PAST streptococcal infection (not current); evidence of recent Group A infection
Titer rises: 1–2 weeks post infection; peaks 3–6 weeks after symptoms
Principle: Passive Agglutination
Unknown: ASO antibodies (patient serum)
Known: latex coated with stabilized Streptolysin O
Agglutination = ASO present = POSITIVE
Qualitative: agglutination = ASO > 200 IU/mL Semi-Quantitative: titer × 200 = ASO in IU/mL
Example: 1:4 → 4 × 200 = 800 IU/mL
False negative: hemolyzed sample (free hemoglobin neutralizes streptolysin O)
Reagent color: YELLOW
RAPID PLASMA REAGIN (RPR) — SYPHILIS
Causative Agent: Treponema pallidum subspecies pallidum (hard chancre)
Haemophilus ducreyi → soft chancre (painful)
Stages of Syphilis:
Primary: single painless hard chancre
Secondary: skin rash, mucous membrane lesions, Condyloma lata
Latent: no symptoms (Early <12 months; Late >12 months)
Tertiary: rare; affects brain (Neurosyphilis), eyes (Ocular), ears (Otosyphilis)
Tests for Syphilis:
Type | Test | Purpose |
|---|---|---|
Non-treponemal | RPR (qualitative only) | Screening |
Non-treponemal | VDRL (qualitative + semi-quant) | Screening |
Treponemal | FTA-ABS, TPHA | Confirmatory (specific) |
Reagin: IgM and IgG antibodies against cardiolipin (non-specific)
RPR Principle: flocculation (larger than precipitation)
Antigen: cardiolipin + charcoal particles + cholesterol + lecithin
Unknown: reagin antibody
Positive: black clumps (charcoal) on white card background
Choline chloride in RPR antigen → inactivates complement → no heating needed
Report as: Reactive / Non-reactive (NOT positive/negative)
Any clumping = REACTIVE; smooth gray = NON-REACTIVE
Rotation: 8 minutes at 100 rpm (mechanical) + 3–4 to-and-fro motions (manual)
Read in "wet" state under bright light
Do NOT read after 20 minutes
False reactive causes: malaria, TB, pregnancy, autoimmune disorders, recent vaccination
Specimen storage: 2–8°C up to 72 hours
WIDAL TEST (TYPHOID FEVER)
Causative Agent: Salmonella enterica serotypes Typhi and Paratyphi A, B
Key Antigens:
O antigen (Ohne): somatic/cell wall; thermostable; shared between Typhi and Paratyphi
H antigen (Hauch): flagellar; thermolabile; species specific
Vi antigen: capsular (unique to Salmonella — NO K antigen)
AH antigen → specific to Paratyphi A
BH antigen → specific to Paratyphi B
Principle: Direct Agglutination
Known: killed bacterial suspension of Salmonella (antigen)
Unknown: patient antibodies
Widal Kit Colors:
Blue stained = O antigen (somatic)
Red stained = H antigen (flagellar)
Interpretation:
Result | Suggestive of |
|---|---|
↑TO antibody only | Recent infection: S. Typhi OR S. Paratyphi A or B |
↑TO + TH | Enteric fever: S. Typhi |
↑TO + AH | Enteric fever: S. Paratyphi A |
↑TO + BH | Enteric fever: S. Paratyphi B |
↑TH only | Convalescent stage / Anamnestic response |
All (TO, TH, AH, BH) ↑ | Post TAB vaccination |
Significant titer: >1:80
Normal individuals may show agglutination up to 1:40
O antibody: early to come, early to leave H antibody: late to come, late to leave
Four-fold rise (2 tube difference): indicates ACTIVE infection
Tube Agglutination Incubation:
O antigen: 48–50°C for 4 hours
H antigen: 48–50°C for 2 hours
OR 37°C for 18–20 hours
Typhidot: more specific and faster than Widal; less cross-reactivity
INFECTIOUS MONONUCLEOSIS (Monospot)
Causative Agent: Epstein-Barr Virus (EBV) = Human Herpesvirus Type 4 (HHV-4)
"Kissing disease" — transmitted mainly through saliva
Pathology:
EBV infects B lymphocytes
Atypical lymphocytes seen = Downey cells (reactive T cells, NOT monocytes)
Lymphocytes >50% WBC; >10% atypical lymphocytes
Heterophile Antibodies:
IgM class; non-specific
React with horse, ox, goat, sheep RBCs
Titer of 1:56 is significant
NOT specific to EBV
Paul-Bunnell-Davidsohn Test:
Antibody | Sheep RBCs | Guinea Pig Kidney | Beef/Ox RBCs |
|---|---|---|---|
Forssman Ab | + | + | – |
Serum Sickness Ab | + | + | + |
IM (Heterophile) Ab | + | – | + |
Mnemonic: GFBM — Guinea pig removes Forssman; Beef removes Mono
Principle of Monospot: Passive Agglutination
Latex coated with Paul-Bunnell antigen (from bovine RBC membranes)
Detects IM heterophile antibodies
Agglutination = POSITIVE
Forssman Antigen: glycolipid heterophile antigen (NOT found normally in humans); found in guinea pig, dog, cat, mouse, horse, fowl RBCs
Semi-quantitative dilutions: 1:2, 1:4, 1:8, 1:16, 1:32
DENGUE DETECTION
Causative Agent: Dengue virus (ssRNA Flaviviridae); 4 serotypes (DENV 1–4)
Vector: Aedes aegypti (urban; 2 silvery lines); Aedes albopictus (rural; 1 silvery line)
NS1 Antigen:
First viral marker to appear; detectable days 1–9 after fever onset
Indicates early dengue infection; does NOT identify serotype
Antibody Timeline:
IgM: detectable 5–10 days after onset (primary); 4–5 days (secondary)
IgG: appears day 14 in primary; rises 1–2 days after onset in secondary; persists for life
Result Interpretation:
Result | Interpretation |
|---|---|
NS1+ only | Early dengue infection |
IgM+ only | Primary dengue infection |
IgG+ only | Secondary or past dengue infection |
IgM+ + IgG+ | Late primary OR early secondary |
All negative | Negative (retest in 3–5 days if suspected) |
No C line | INVALID |
Test: Immunochromatographic assay (Bioline Dengue Duo)
NS1 Ag: 3 drops (100 µL) specimen
IgG/IgM: 10 µL specimen + 4 drops assay diluent
Read at 15–20 minutes (do NOT read after 20 min)
Any line, no matter how faint = POSITIVE
Cross-reactivity: with other Flaviviruses (West Nile, Zika, Yellow Fever, Japanese Encephalitis)
HEPATITIS
Transmission Summary:
A & E: fecal-oral (contaminated water) — "tAE"
B & C: blood/body fluids
D: requires HBV (defective virus)
Type | Nucleic Acid | Family | Vaccine |
|---|---|---|---|
A | RNA | Picornaviridae | Yes |
B | DNA | Hepadnaviridae | Yes |
C | RNA | Flaviviridae | No |
D | RNA | Deltavirus | Yes (via HBV vaccine) |
E | RNA | Hepeviridae | Yes |
Hepatitis B Serological Markers:
Marker | Significance |
|---|---|
HBsAg | Active HBV infection (acute or chronic); first detectable marker |
HBeAg | Active viral replication; high infectivity |
HBcAg | Found in liver only (NOT in serum); core antigen |
Anti-HBc (IgM) | Recent/acute infection; window period marker |
Anti-HBe | Convalescent phase; seroconversion; healing |
Anti-HBs | Full recovery AND immunity (also from vaccination) |
HBsAg: detectable 2 weeks–2 months before symptoms; persists 2–3 months
Immunized with HBsAg: HBsAg(–), Anti-HBs(+), Anti-HBc(–) Natural immunity: HBsAg(–), Anti-HBs(+), Anti-HBc(+)
Hepatitis C: "Non-A/Non-B"; Gold standard = RT-PCR; Anti-HCV detectable 8–10 weeks post-exposure
Hepatitis D:
Co-infection: (+) IgM anti-HBc
Superinfection: (+) IgG anti-HBc
HBsAg Test Principle: Immunochromatographic Assay (sandwich)
Specimen: 100 µL serum/plasma
Read at 20 minutes
HIV
Causative Agent: RNA retrovirus; Family Retroviridae, Genus Lentivirinae
Structural Genes:
gag gene: encodes p24 (capsid), p17 (matrix)
pol gene: encodes reverse transcriptase (p66/p51), integrase (p31), protease (p10)
env gene: encodes gp160 → gp120 (docking/attachment) + gp41 (fusion)
Key Proteins:
gp120 = attachment to CD4 receptor
gp41 = membrane fusion
p24 = key early marker of infection; forms capsid
p17 = matrix protein (between core and envelope)
Co-receptors:
CXCR4 → T lymphocytes (X4 or T-tropic strains)
CCR5 → Macrophages (R5 or M-tropic strains)
Tip: X in CXCR4 = T cells; CC in CCR5 = Macrophages
Replication Cycle:
Attachment (gp120 + CD4) → 2. Fusion (gp41) → 3. Reverse transcription (RNA→DNA) → 4. Integration (provirus) → 5. Replication → 6. Assembly → 7. Budding + Protease cleavage → mature virion
Stages of HIV:
Stage | CD4 Count | Feature |
|---|---|---|
1: Acute | >500 cells/µL | Flu-like symptoms; high viral load |
2: Chronic | 200–499 cells/µL | Asymptomatic; clinical latency |
3: AIDS | <200 cells/µL | Opportunistic infections |
Normal CD4:CD8 ratio = 2:1; In AIDS = <0.5:1 (inverted)
Transmission (most to least common): Sexual contact → Parenteral → Vertical (perinatal)
NOT transmitted by saliva
ART Drug Classes:
Entry inhibitors (block CCR5 binding)
Fusion inhibitors (block gp41 fusion)
Reverse transcriptase inhibitors (block RNA→DNA)
Integrase inhibitors (block provirus integration)
Protease inhibitors (block protein cleavage)
Lab Diagnosis Algorithm (CDC 2014):
Screening: 4th-generation ELISA (detects HIV-1/2 Ab + p24 Ag simultaneously)
Differentiation: Geenius HIV 1/2 Supplemental Assay (replaces Western Blot)
Confirmatory/Early: Nucleic Acid Testing (NAT/HIV RNA) — detectable by day 10
First markers to appear (in order): HIV RNA → p24 antigen → HIV IgM → HIV IgG → Western Blot bands
Western Blot Positive: ≥2 of these 3 bands: p24, gp41, gp120/160
p24 + gp41 = POSITIVE
gp41 alone = INDETERMINATE
Geenius HIV 1/2:
HIV-1 positive: reactivity to gp160 + gp41 OR 1 envelope + p24 or p31
HIV-2 positive: reactivity to BOTH gp36 AND gp140
Philippine rHIVda: T1 (screening) → T2 → T3 (Geenius); all 3 positive = HIV confirmed
Disease Monitoring:
CD4 count: best indicator of immune function; done by flow cytometry
Viral load (HIV RNA copies/mL): monitors ART effectiveness; goal = undetectable
U = U: Undetectable = Untransmittable
ACUTE PHASE REACTANTS (CRP topic)
Positive APR (increase): CRP, Fibrinogen, Haptoglobin, Ceruloplasmin, Complement C3/C4, Serum Amyloid A, Anti-chymotrypsin
Negative APR (decrease): Albumin (most abundant blood protein), Transferrin, Alpha-fetoprotein
Regulated by: IL-6, IL-1, TNF-α (pro-inflammatory cytokines) Produced by: Liver (hepatocytes)
Systemic Response Categories:
Neuroendocrine: fever, HPA axis activation (CRH→ACTH→cortisol)
Metabolic: muscle breakdown, ↑CPK
Hematologic: leukocytosis, thrombocytosis, anemia
Biochemical: ↓Fe, ↓Zn, ↑Cu
QUICK COMPARISON TABLE: CRP vs RF vs ASO
Feature | CRP | RF | ASO |
|---|---|---|---|
What detected | Antigen (CRP) | Antibody (RF) | Antibody (ASO) |
Principle | Reverse Passive | Passive Agglutination | Passive Agglutination |
Known reagent | Anti-CRP Ab on latex | Human IgG on latex | Streptolysin O on latex |
Reagent color | Blue | White | Yellow |
Positive threshold | >6 IU/mL | >20 IU/mL | >200 IU/mL |
Conversion factor | ×6 | ×12 (or ×20) | ×200 |
Tube used | Red/Gold top | Red/Gold top | Red/Gold top |
Fasting required | No | No | No |
Reject specimens | Lipemia, hemolysis, bacteria | Same | Same + hemolysis causes false negative |
AGGLUTINATION INHIBITION vs HEMAGGLUTINATION INHIBITION
Agglutination Inhibition | Hemagglutination Inhibition | |
|---|---|---|
Positive result | NO agglutination (inhibited) | NO agglutination |
Detects | Antigen | Antibody |
Example | Pregnancy test | Viral Ab test |
Good luck on your exams! Fighting and Faithing!